Novartis AG
Tablet Formulation of 2-Fluoro-N-Methyl-4-[7-(Quinolin-6-Ylmethyl) Imidazo [1,2-B] [1,2,4] Triazin-2-YL] Benzamide
Last updated:
Abstract:
The present invention is related to tablets comprising of 2-fluoro-N-methyl-4-[7-(quinolin-6-ylmethyl)imidazo[1,2-b][1,2,4]triazin-- 2-yl]benzamide, processes for the production thereof, and uses in the treatment of certain cancers.
Status:
Application
Type:
Utility
Filling date:
13 Feb 2020
Issue date:
22 Apr 2021